Circulation, Vol 90, 2203-2206, Copyright © 1994 by American Heart Association
H Matsuno, JM Stassen, J Vermylen and H Deckmyn
BACKGROUND--RGD-containing peptides are able to prevent binding of ligands
to certain integrins such as alpha IIb beta 3 (glycoprotein IIb/IIIa) and
alpha v beta 3 and as such are inhibitors for platelet aggregation and
smooth muscle cell migration, both of which are involved in neointima
formation. METHODS AND RESULTS--Hamster carotid arteries were damaged, and
neointima formation was determined at different time points. G4120, a
cyclic RGD-containing peptide, was administered continuously intravenously
by an implanted osmotic pump. Neointima formation was inhibited dose
dependently. The inhibition was strongest when treatment was started before
the vascular injury and continued for the full observation period.
Treatment started after the damage and maintained until neointima
assessment or started before and stopped earlier was less effective.
CONCLUSIONS--Inhibition of integrin function by an RGD-containing peptide
results in reduction of the development of a neointima. This effect is due
both to an early event, which could be due to inhibition of secretion of
PDGF by the platelets with blocked alpha IIb beta 3, and to a late event,
possibly by interference with smooth muscle cell alpha v beta 3.
ARTICLES
Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation
Center for Molecular and Vascular Biology, K.U. Leuven, Belgium.
This article has been cited by other articles:
 |
|
 |
|
  H.-Y. Chiang, V. A. Korshunov, A. Serour, F. Shi, and J. Sottile Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1074 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Asano, H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki Increased Expression of Integrin {alpha}v{beta}3 Contributes to the Establishment of Autocrine TGF-{beta} Signaling in Scleroderma Fibroblasts J. Immunol., December 1, 2005; 175(11): 7708 - 7718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Sadeghi, S. Krassilnikova, J. Zhang, A. A. Gharaei, H. R. Fassaei, L. Esmailzadeh, A. Kooshkabadi, S. Edwards, P. Yalamanchili, T. D. Harris, et al. Detection of Injury-Induced Vascular Remodeling by Targeting Activated {alpha}v{beta}3 Integrin In Vivo Circulation, July 6, 2004; 110(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ma, T. M. Calderon, T. Kessel, A. W. Ashton, and J. W. Berman Mechanisms of Hepatocyte Growth Factor-Mediated Vascular Smooth Muscle Cell Migration Circ. Res., November 28, 2003; 93(11): 1066 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsuno, A. Ishisaki, K. Nakajima, K. Okada, S. Ueshima, O. Matsuo, and O. Kozawa Lack of {alpha}2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice Blood, November 15, 2003; 102(10): 3621 - 3628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kanzaki and M. Otabe Latent Transforming Growth Factor-{beta} Binding Protein-1, a Component of Latent Transforming Growth Factor-{beta} Complex, Accelerates the Migration of Aortic Smooth Muscle Cells in Diabetic Rats Through Integrin-{beta}3 Diabetes, March 1, 2003; 52(3): 824 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dufourcq, T. Couffinhal, P. Alzieu, D. Daret, C. Moreau, C. Duplaa, and J. Bonnet Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation Cardiovasc Res, March 1, 2002; 53(4): 952 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries Circulation, November 6, 2001; 104(19): 2331 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lele, M. Sajid, N. Wajih, and G. A. Stouffer Eptifibatide and 7E3, but Not Tirofiban, Inhibit {alpha}v{beta}3 Integrin-Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin Circulation, July 31, 2001; 104(5): 582 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ichii, H. Koyama, S. Tanaka, S. Kim, A. Shioi, Y. Okuno, E. W. Raines, H. Iwao, S. Otani, and Y. Nishizawa Fibrillar Collagen Specifically Regulates Human Vascular Smooth Muscle Cell Genes Involved in Cellular Responses and the Pericellular Matrix Environment Circ. Res., March 16, 2001; 88(5): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thibault, P. Tardif, and G. Lapalme Comparative Specificity of Platelet {alpha}IIb{beta}3 Integrin Antagonists J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 690 - 696. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. A. Chico, J. Chamberlain, J. Gunn, N. Arnold, S. L. Bullens, T. R. Gadek, S. E. Francis, S. Bunting, M. Horton, L. Shepherd, et al. Effect of Selective or Combined Inhibition of Integrins {{alpha}}IIb{beta}3 and {{alpha}}v{beta}3 on Thrombosis and Neointima After Oversized Porcine Coronary Angioplasty Circulation, February 27, 2001; 103(8): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H Baron, E. P Moiseeva, D. P de Bono, K. R Abrams, and A. H Gershlick Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis Cardiovasc Res, December 1, 2000; 48(3): 464 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Palumbo, C. Gaetano, G. Melillo, E. Toschi, A. Remuzzi, and M. C. Capogrossi Shear Stress Downregulation of Platelet-Derived Growth Factor Receptor-{beta} and Matrix Metalloprotease-2 Is Associated With Inhibition of Smooth Muscle Cell Invasion and Migration Circulation, July 11, 2000; 102(2): 225 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Y.-F. Chen, S. S. Kelpke, S. Oparil, and J. A. Thompson Estrogen Attenuates Integrin-{beta}3-Dependent Adventitial Fibroblast Migration After Inhibition of Osteopontin Production in Vascular Smooth Muscle Cells Circulation, June 27, 2000; 101(25): 2949 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Bendeck, C. Irvin, M. Reidy, L. Smith, D. Mulholland, M. Horton, and C. M. Giachelli Smooth Muscle Cell Matrix Metalloproteinase Production Is Stimulated via {alpha}v{beta}3 Integrin Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1467 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kanda, M. Kuzuya, M. A. Ramos, T. Koike, K. Yoshino, S. Ikeda, and A. Iguchi Matrix Metalloproteinase and {alpha}v{beta}3 Integrin-Dependent Vascular Smooth Muscle Cell Invasion Through a Type I Collagen Lattice Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 998 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chandrasekar and J.-F. Tanguay Platelets and restenosis J. Am. Coll. Cardiol., March 1, 2000; 35(3): 555 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kuykindoll, H Nishimura, D. Thomason, and S. Nishimoto Osteopontin expression in spontaneously developed neointima in fowl (Gallus gallus) J. Exp. Biol., January 1, 2000; 203(2): 273 - 282. [Abstract] [PDF]
|
|
|
|
|
|
Acute Platelet Inhibition With Abciximab Does Not Reduce In-Stent Restenosis (ERASER Study) Circulation, August 24, 1999; 100(8): 799 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nawata, I. Ohno, S. Isoyama, J. Suzuki, S. Miura, J. Ikeda, and K. Shirato Differential expression of {alpha}1, {alpha}3 and {alpha}5 integrin subunits in acute and chronic stages of myocardial infarction in rats Cardiovasc Res, August 1, 1999; 43(2): 371 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Scarborough, N. S. Kleiman, and D. R. Phillips Platelet Glycoprotein IIb/IIIa Antagonists : What Are the Relevant Issues Concerning Their Pharmacology and Clinical Use? Circulation, July 27, 1999; 100(4): 437 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Coleman, G. A. Braden, M. C. Willingham, and D. C. Sane Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor ({alpha}vß3), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits Circ. Res., June 11, 1999; 84(11): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kastrati, A. Schomig, M. Seyfarth, W. Koch, S. Elezi, C. Bottiger, J. Mehilli, K. Schomig, and N. von Beckerath PlA Polymorphism of Platelet Glycoprotein IIIa and Risk of Restenosis After Coronary Stent Placement Circulation, March 2, 1999; 99(8): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Chang, A. Kuo, E. S. Barnathan, and S. S. Okada Urokinase Receptor-Dependent Upregulation of Smooth Muscle Cell Adhesion to Vitronectin by Urokinase Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1855 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Deitch, J. K. Williams, M. R. Adams, C. A. Fly, D. M. Herrington, R. E. Jordan, M. T. Nakada, J. A. Jakubowski, and R. L. Geary Effects of ß3-Integrin Blockade (c7E3) on the Response to Angioplasty and Intra-Arterial Stenting in Atherosclerotic Nonhuman Primates Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1730 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Plescia, M. S. Conte, G. VanMeter, G. Ambrosini, and D. C. Altieri Molecular Identification of the Cross-reacting Epitope on alpha Mbeta 2 Integrin I Domain Recognized by Anti-alpha IIbbeta 3 Monoclonal Antibody 7E3 and Its Involvement in Leukocyte Adherence J. Biol. Chem., August 7, 1998; 273(32): 20372 - 20377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gershlick Endovascular manipulation to restrict restenosis Vascular Medicine, August 1, 1998; 3(3): 177 - 188. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Slepian, S. P. Massia, B. Dehdashti, A. Fritz, and L. Whitesell ß3-Integrins Rather Than ß1-Integrins Dominate Integrin-Matrix Interactions Involved in Postinjury Smooth Muscle Cell Migration Circulation, May 12, 1998; 97(18): 1818 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A H Gershlick and J Baron Dealing with in-stent restenosis Heart, April 1, 1998; 79(4): 319 - 323. [Full Text]
|
|
|
|
|
|
P. Dufourcq, H. Louis, C. Moreau, D. Daret, M. R. Boisseau, J. M. D. Lamaziere, and J. Bonnet Vitronectin Expression and Interaction With Receptors in Smooth Muscle Cells From Human Atheromatous Plaque Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 168 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lundgren, B. Vinogradsky, A. Guala, and S. Fujii A Vitronectin Receptor Antagonist Inhibits Neointimal Formation After Balloon Arterial Injury in Rabbits in Vivo Vascular and Endovascular Surgery, January 1, 1998; 32(1): 47 - 53. [Abstract] [PDF]
|
|
|
|
|
|
S.S. Srivatsa, L. A Fitzpatrick, P. W Tsao, T. M Reilly, D. R Holmes Jr, R. S Schwartz, and S. A Mousa Selective {alpha}v{beta}3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury:: Evidence for the functional importance of integrin {alpha}v{beta}3 and osteopontin expression during neointima formation Cardiovasc Res, December 1, 1997; 36(3): 408 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gawaz, F.-J. Neumann, T. Dickfeld, A. Reininger, H. Adelsberger, A. Gebhardt, and A. Schomig Vitronectin Receptor ({alpha}vß3) Mediates Platelet Adhesion to the Luminal Aspect of Endothelial Cells : Implications for Reperfusion in Acute Myocardial Infarction Circulation, September 16, 1997; 96(6): 1809 - 1818. [Abstract] [Full Text]
|
|
|
|
|
|
H. Matsuno, O. Kozawa, M. Niwa, and T. Uematsu Inhibition of von Willebrand Factor Binding to Platelet GP Ib by a Fractionated Aurintricarboxylic Acid Prevents Restenosis After Vascular Injury in Hamster Carotid Artery Circulation, August 19, 1997; 96(4): 1299 - 1304. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Pickering, S. Uniyal, C. M. Ford, T. Chau, M. A. Laurin, L. H. Chow, C. G. Ellis, J. Fish, and B. M. C. Chan Fibroblast Growth Factor-2 Potentiates Vascular Smooth Muscle Cell Migration to Platelet-Derived Growth Factor : Upregulation of {alpha}2ß1 Integrin and Disassembly of Actin Filaments Circ. Res., May 19, 1997; 80(5): 627 - 637. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Aggarwal, D. C. Ireland, M. A. Azrin, M. D. Ezekowitz, D. P. de Bono, and A. H. Gershlick Antithrombotic Potential of Polymer-Coated Stents Eluting Platelet Glycoprotein IIb/IIIa Receptor Antibody Circulation, December 15, 1996; 94(12): 3311 - 3317. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hoshiga, C. E. Alpers, L. L. Smith, C. M. Giachelli, and S. M. Schwartz {alpha}vß3 Integrin Expression in Normal and Atherosclerotic Artery Circ. Res., December 1, 1995; 77(6): 1129 - 1135. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Lefkovits, E. F. Plow, and E. J. Topol Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine N. Engl. J. Med., June 8, 1995; 332(23): 1553 - 1559. [Full Text] [PDF]
|
|
|
|
|
|
C. R. Hauck, D. A. Hsia, and D. D. Schlaepfer Focal Adhesion Kinase Facilitates Platelet-derived Growth Factor-BB-stimulated ERK2 Activation Required for Chemotaxis Migration of Vascular Smooth Muscle Cells J. Biol. Chem., December 22, 2000; 275(52): 41092 - 41099. [Abstract] [Full Text] [PDF]
|
|